Lexington Biosciences, Inc. Stock Other OTC
Equities
LXGTF
CA5290204067
Medical Equipment, Supplies & Distribution
Sales 2022 | - | Sales 2023 | - | Capitalization | 35.62 48.96 |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | - |
Net cash position 2022 * | - 0 | Net cash position 2023 * | - 0 | EV / Sales 2023 | - |
P/E ratio 2022 |
-
| P/E ratio 2023 |
-
| Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 13.79% |
Managers | Title | Age | Since |
---|---|---|---|
Donald McInnes
CEO | Chief Executive Officer | 60 | 20-04-15 |
Bryan Disher
DFI | Director of Finance/CFO | 66 | 16-12-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bryan Disher
DFI | Director of Finance/CFO | 66 | 16-12-20 |
Tamara Manuel
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
-3.54% | 184B | |
-0.58% | 109B | |
-2.74% | 68.37B | |
+4.84% | 51.56B | |
+10.40% | 44.69B | |
+4.28% | 41.49B | |
+2.87% | 26.75B | |
+4.61% | 26.7B | |
+14.15% | 25.68B |